PRKN and Alzheimer disease: In both Aβ and tau C. elegans models of AD, mitophagy enhancers reversed memory impairment through PINK- 1-, Parkinson’s disease-related-1; parkin-, or DAF-16/FOXO-controlled germline-tumor affecting-1-dependent pathways.